刘景丰
更新日期：2018-09-20
刘景丰，二级教授、博士生导师，百千万人才工程国家级人选，国务院政府特殊津贴专家，国家卫计委与福建省卫计委有突出贡献中青年专家，福建省科技创新领军人才，福建省劳动模范。主要从事肝癌的转化医学研究（早期诊断新技术与新方法、免疫治疗与精准医学）及临床工作。现主持国家自然科学基金等省部级科研项目10余项；在国际知名期刊上发表SCI收录论文60多篇，授权国家发明专利13项。荣获国家科技进步二等奖1项，省部级科技奖5项。
地址： 福建省福州市西洪路312号福建医科大学孟超肝胆医院
电话： 0591-83705927 邮箱：drjingfeng@126.com
研究方向：肿瘤学、精准医学、肿瘤诊疗新技术
代表性论文：
1. G Chen#, Z Cai#, Z Li, X Dong, L Qiu, M Lin, X Liu *, and J Liu *. Clonal evolution in advanced hepatocellular carcinoma patients. International Journal of Cancer, 2018, DOI: 10.1002/ijc.31844.
2. X Dong#, G Chen#, Z Cai#, Z Li, L Qiu, H Xu, X Liu *, and J Liu *. CDK13 RNA over-editing mediated by ADAR1 associates with poor prognosis of hepatocellular carcinoma patients. Cellular Physiology and Biochemistry, 2018, 47:2602-2612.
3. M Wu, J Li, X Lin, Z Wei, D Zhang, B Zhao, X Liu*, and J Liu*. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery. Biomaterials Science, 2018, 6(6):1457-1468.
4. M Wu#, X Lin#, X Tan, J Li, Z Wei, D Zhang, Y Zheng, A Zheng, B Zhao, Y Zeng, X Liu*, and J Liu*. Photoresponsive Nanovehicle for Two Independent Wavelength-Triggered Sequential Release of P-gp shRNA and Doxorubicin to Optimize and Enhance Synergistic Therapy of Multidrug-resistant Cancer. ACS Applied Materials and Interfaces, 2018, 10:19416-19427.
6. X Zhang, X Tan, D Zhang, N Liao, Y Zheng, A Zheng, Y Zeng, X Liu*, and J Liu*. A cancer cell specific targeting nanogel for combination of mRNA-responsive photodynamic and chemo-therapy. Chemical Communications, 2017, 53, 9979 – 9982.
7. X Zhang, N Liao, G Chen, A Zheng, Y Zeng, X Liu*, and J Liu*. A turn-on fluorescent nanosensor for simultaneous visualization of dual-targets involved in cell apoptosis in living cells. Nanoscale, 2017, 9: 10861-10868.
8. Z Cai#, G Chen#, Y Zeng, X Dong, M Lin, X Huang, D Zhang, XLLiu * and J Liu *. Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma. International Journal of Cancer, 2017, 141(5): 977-985.
9. D Zhang, A Zheng, J Li, M Wu, Z Cai, L Wu, Z Wei, H Yang, X Liu*, and J Liu*. Tumour micro-environment activitable self-assembled DNA hybrids for pH and redox dual-responsive chemotherapy / PDT treatment of Hepatocellular carcinoma. Advanced Science, 2017, 1600460, DOI: 10.1002/advs.201600460.
10. D Zhang, M Wu, Y Zeng, L Wu, X Han, X Liu* and J Liu*. Chlorin e6 conjugated poly (dopamine) nanosphere as PDT/PTT dual-modal therapeutic agent for enhanced cancer therapy. ACS Applied Materials and Interfaces, 2015, 7(15):8176-87.